Despite a vibrant maker culture, and one of the top biotech industries in the nation, Seattle has never had a strong DIYbio community — a loose movement of amateur and professional scientists, working on creative… Read More
BGI, the Shenzhen, China,-based genomics giant, announced today that it has opened a Seattle office as part of a major expansion in North America. The company is one of the largest… Read More
Immunotherapy is simple in theory, but endlessly complex in practice. This type of treatment uses the body’s immune system — a system designed to find and attack microscopic invaders —… Read More
Seattle-based Nohla Therapeutics, a biotech startup spun out of the Fred Hutchinson Cancer Research Center, just announced a whopping $43.5 million Series A round, bringing the startup’s total funding to date… Read More
Seattle-based biotech company PhaseRx develops drug candidates to treat rare, often life-threatening liver diseases, and one of their candidates just got a boost from the FDA. The company’s leading drug, called… Read More
There are two basic models for scientific research — industry and academia — and each has its strengths. Academia can support sustained, long-term research. Industry is better at pushing the envelope with its entrepreneurial… Read More
The Seattle-based Infectious Disease Research Institute (IDRI), a product-focused nonprofit that fights infectious diseases around the world, announced today that it will receive $15 million from pharmaceutical giant Eli Lilly to… Read More
Back in 2009, immunotherapy was considered a long shot. The process involves reprogramming a patient’s T cells, important elements of the immune system, so that they attack cancerous cells. But since… Read More
To many, immunotherapies — treatments that use a patient’s immune system to fight cancer— sound like something from an episode of Star Trek. In CAR T cell therapy, for example, a… Read More
What does it take for a region to become truly revolutionary? Dr. Richard Klausner, co-founder and director of biotechnology company Juno Therapeutics, says it is all about time, place, and capitalizing on unique… Read More
Is Jeff Bezos looking for the fountain of youth? Possibly, if his latest investment provides any clues. The billionaire founder of Amazon.com is among the investors in Unity Biotechnology, a San… Read More
In a study to be published this month, University of Washington researchers announce a promising discovery: electrodes placed on the surface of the brain could help those with spinal cord… Read More
Gene therapy — the process of genetically altering cells to treat disease — is a highly promising process being studied as a way to cure devastating conditions like genetic disorders, HIV,… Read More
While Washington state’s biotech industry is on the up and up, it still lags far behind hubs like San Francisco and Cambridge, Mass. Washington’s biotech industry is not only lagging… Read More
Sound Pharmaceuticals, a Seattle startup developing therapies and preventative treatments for hearing loss, is in the midst of a $30 million investment round with more $4 million raised so far, according to… Read More
Take a quick browse through Seattle’s biotech scene, and you’ll notice a pattern. Immunotherapy — using the body’s immune system to fight cancer — is the hottest topic in biotechnology nowadays, and it… Read More
In the quest for a better understanding of the human body, the automated DNA sequencer was a breakthrough innovation, giving scientists new insights into the hidden code of life. The… Read More
Bothell-based Seattle Genetics and Tokyo-based Takeda Oncology announced the success of their phase 3 clinical trial of Adcetris today, an immunotherapy drug that treats lymphoma, a cancer of white blood cells. Fifty-six percent of patients in… Read More
Seattle-based biotech startup Kineta announced today that it has received an undisclosed amount of funding to expand research that could potentially combat the Zika virus. The funding comes from the National Institute… Read More
Seattle’s Alpine Immune Sciences says it has closed a $48 million Series A financing round, to fund the development of next-generation therapies that tweak the body’s immune system to fight… Read More
Synthetic genomes and gene editing are big things today, but the next big things in biotechnology could be proteins that are designed and edited on computers – and are then synthesized… Read More
The way BioViva founder Elizabeth Parrish sees it, biological aging is a disease – and she’s willing to bet her life on a cure. Last fall, the 45-year-old Seattle-area woman underwent an experimental type… Read More
It’s a bleak time on Wall Street, at least if you’re trying to take your company public. Just six venture-backed companies — all of them in the life sciences and… Read More
The University of Washington held its first annual Health Innovation Challenge (HIC) Thursday—bringing innovators in entrepreneurship, business and health science together with students from regional universities. The challenge was a… Read More
Bruce Montgomery, one of Seattle’s longtime biotech veterans, was among the investors that participated in a $10 million funding round for M3 Biotechnology, a startup focused on fighting brain ailments,… Read More
Editas Medicine’s entry into the stock market with a $94.4 million initial public offering appears to be sparking positive signals for the company as well as the nascent gene-editing industry.… Read More
One of the giants of gene sequencing, Illumina, has spun off a new $100 million company called Grail to create an all-in-one blood test for cancer – and its investors include… Read More
Seattle-based Accelerator Corp. will be looking to spend a ton of money on biotech startups soon, but not only in the Emerald City. The life sciences investment company announced today that it… Read More
Chris Rivera is stepping down as president and CEO of the Washington Biotechnology & Biomedical Association, a nonprofit biotech trade group. He joined WBBA in 2009 to help enhance the life science sector… Read More
Seattle is well known for making airplanes, coffee and software. But when it comes to cutting-edge biotechnology and health services, the region doesn’t always get top billing. That point of… Read More